Related content

From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a ‘routine’ diabetes clinic?

By Distiller L.   Joffe B.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2793-2794

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105–2108

By Schwartz R.   Neu J.   Schatz D.   Atkinson M.   Wasserfall C.  

Diabetologia, Vol. 50, Iss. 1, 2007-01 ,pp. : 220-221

Springer Publishing Company

Access to resources Recommend Favorite

A randomized crossover study of the efficacy and safety of switching from insulin glargine to insulin degludec among patients with type 1 diabetes

By Yamada Kentaro   Nakayama Hitomi   Sato Shuichi   Tajiri Yuji   Kaku Hiroh   Tokubuchi Ichiro   Kato Tamotsu   Soejima Eri   Ohki Tsuyoshi  

Diabetology International, Vol. 5, Iss. 1, 2014-03 ,pp. : 74-77

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Insulin Glargine in Type 1 and 2 Diabetes Mellitus

By McKeage K.   Goa K.L.  

Treatments in Endocrinology, Vol. 1, Iss. 1, 2002-01 ,pp. : 55-58

Adis International

Access to resources Recommend Favorite

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes

By Fonseca V.   Schweizer A.   Albrecht D.   Baron M.   Chang I.   Dejager S.  

Diabetologia, Vol. 50, Iss. 6, 2007-06 ,pp. : 1148-1155

Springer Publishing Company

Access to resources Recommend Favorite